Susceptibility to Mycobacterial Infections in Children With X-Linked Chronic Granulomatous Disease: A Review of 17 Patients Living in a Region Endemic For Tuberculosis
The DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Chronic granulomatous disease (CGD) is a rare disorder of phagocytic oxidative bursts leading to recurrent pyogenic infections. Affected individuals are most prone to infections caused by staphylococci, Salmonella, Candida, and Aspergillus, but previously we observed a high incidence of Mycobacterium tuberculosis infection in Chinese children with CGD. OBJECTIVE: To determine the spectrum of infections in patients with X-linked CGD, with an emphasis on mycobacterial infections, and to review all CYBB gene mutations identified in our center. RESULTS: From 1988 to 2005, 17 Chinese male children were diagnosed to have X-linked CGD. Fifteen mutations were identified, including 3 splice site defects (IVS1-1G>C, 266G>A, IVS3-1G>A), 5 missense mutations (591T>C, 627T>A, 949T>A, 1039T>A, 1512G>C), 3 nonsense mutations (882C>T, 1451C>A, 1569G>T), 1 insertion (756_757insA), and 3 deletions (660_662delTTC, 727delT, 1341delT). Eight of these were novel mutations. Recurrent pneumonia, lymphadenitis, and bacterial skin abscess were the commonest types of infection. Seven patients had tuberculosis (TB). Seven patients had prolonged scarring or abscess formation at the Calmette-Guérin bacillus (BCG) injection site, and 1 had disseminated BCG infection. Three patients had pulmonary aspergillosis. Four patients underwent hemopoietic stem cell transplantation, but 2 died of complications. CONCLUSIONS: Patients with CGD are susceptible to TB and BCG complications. Our observation suggests that oxidative burst is probably important in host defense against mycobacterial infections. Because interferon-gamma is the key cytokine involved in mycobacterial immunity, there may be a stronger indication for its use in CGD patients living in areas endemic for TB.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Extrapulmonary tuberculosis, including lymphatic tuberculosis, is more common among immunocompromised patients, including those with HIV infection [20, 21].”
From Current diagnosis and management of peripheral tuberculous lymphadenitis. (2011) · cites this paper as [21]
Citations
Cites
An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection.
Flynn, J. L., Chan, J., Triebold, K. J., Dalton, D. K., Stewart, T. A., & Bloom, B. R. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.6.2249 · Cited by 2,465 · cited 1×
“In the past decade, the role of IFN- in mycobacterial immunity has been increasingly recognized.(25,26) IFN- is produced by mycobacteria-specific CD4 and CD8 T cells and activates macrophage to kill the bacilli.”
Background(2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.4.16141 · Cited by 1,525
Genetic Dissection of Immunity to Mycobacteria: The Human Model
Casanova, J.-L., & Abel, L. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.081501.125851 · Cited by 991
Genetic, Biochemical, and Clinical Features of Chronic Granulomatous Disease
Segal, B. H., Leto, T. L., Gallin, J. I., Malech, H. L., & Holland, S. M. (2000) · Medicine · doi:10.1097/00005792-200005000-00004 · Cited by 883 · cited 2×
“An increased incidence of TB was not observed in other studies on CGD in the white population.(2) We have performed a retrospective review on the clinical course and infective complications in 17 X-linked patients with CGD with an emphasis on mycobacterial infections.”
BackgroundResultA Controlled Trial of Interferon Gamma to Prevent Infection in Chronic Granulomatous Disease
The International Chronic Granulomatous Disease Cooperative Study Group* (1991) · New England Journal of Medicine · doi:10.1056/nejm199102213240801 · Cited by 830
North, R. J., & Jung, Y.-J. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104635 · Cited by 677 · cited 1×
“In the past decade, the role of IFN- in mycobacterial immunity has been increasingly recognized.(25,26) IFN- is produced by mycobacteria-specific CD4 and CD8 T cells and activates macrophage to kill the bacilli.”
BackgroundInborn errors of IL-12/23- and IFN-γ-mediated immunity: molecular, cellular, and clinical features
Filipe-Santos, O., Bustamante, J., Chapgier, A., Vogt, G., de Beaucoudrey, L., Feinberg, J., Jouanguy, E., Boisson-Dupuis, S., Fieschi, C., Picard, C., et al. (2006) · Seminars in Immunology · doi:10.1016/j.smim.2006.07.010 · Cited by 464 · cited 1×
“Genetic defects in IFN- receptor 1, IFN- receptor 2, and signal transducer and activator of transcription 1 (STAT-1) are associated with impaired cellular responses to IFN- , whereas defects in interleukin-12B (IL12B), IL-12 receptor 1, and NF- B essential modulator are associated with impaired IL-12/IL-23dependent IF…”
BackgroundMutations in the X-linked and autosomal recessive forms of chronic granulomatous disease
Roos, D., de Boer, M., Kuribayashi, F., Meischl, C., Weening, R., Segal, A., Ahlin, A., Nemet, K., Hossle, J., Bernatowska-Matuszkiewicz, E., et al. (1996) · Blood · doi:10.1182/blood.v87.5.1663.1663 · Cited by 424
Clinical features of dominant and recessive interferon γ receptor 1 deficiencies
Dorman, S. E., Picard, C., Lammas, D., Heyne, K., van Dissel, J. T., Baretto, R., Rosenzweig, S. D., Newport, M., Levin, M., Roesler, J., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17552-1 · Cited by 422
Latent tuberculosis: mechanisms of host and bacillus that contribute to persistent infection
Tufariello, J. M., Chan, J., & Flynn, J. L. (2003) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(03)00741-2 · Cited by 403 · cited 1×
“IFN- is produced by mycobacteria-specific CD4 and CD8 T cells and activates macrophage to kill the bacilli.(27) IFN- knock-out mice were most susceptible to virulent M.”
BackgroundOxidative killing of microbes by neutrophils
Roos, D., van Bruggen, R., & Meischl, C. (2003) · Microbes and Infection · doi:10.1016/j.micinf.2003.09.009 · Cited by 358 · cited 1×
“aureus and Gram-negative bacteria including various Salmonella species, Klebsiella, and Burkholderia cepacia.(10) In our cohort, patients were most frequently affected by mycobacteria, including M.”
BackgroundDisseminated Bacille Calmette‐Guerin Disease After Vaccination: Case Report and Review
Talbot, E. A., Perkins, M. D., Silva, S. F. M., & Frothingham, R. (1997) · Clinical Infectious Diseases · doi:10.1086/513642 · Cited by 341
Immunological conditions of children with BCG disseminated infection
Casanova, J.-L., Jouanguy, E., Lamhamedi, S., Blanche, S., & Fischer, A. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91421-8 · Cited by 258 · cited 1×
“Apart from CGD, disseminated BCG infection has also been reported in other primary immunodeficiency disorders such as severe combine immunodeficiency syndrome and Di George syndrome.(38,39) In the past decade, there has been advancement in knowledge on host immunity against mycobacterial disease.”
BackgroundBacille Calmette-Guerin Vaccine--Induced Disease in HIV-Infected and HIV-Uninfected Children
Hesseling, A. C., Rabie, H., Marais, B. J., Manders, M., Lips, M., Schaaf, H. S., Gie, R. P., Cotton, M. F., van Helden, P. D., Warren, R. M., et al. (2006) · Clinical Infectious Diseases · doi:10.1086/499953 · Cited by 255
Long-Term Interferon- Therapy for Patients with Chronic Granulomatous Disease
Marciano, B. E., Wesley, R., De Carlo, E. S., Anderson, V. L., Barnhart, L. A., Darnell, D., Malech, H. L., Gallin, J. I., & Holland, S. M. (2004) · Clinical Infectious Diseases · doi:10.1086/422993 · Cited by 251
Second IUATLD study on complications induced by intradermal BCG-vaccination.
Lötte, A., WASZ‐HÖCKERT, O., Poisson, N., Engbæk, H. C., Landmann, H. R., Quast, U., Andrasofszky, B., Lugosi, L., Vadász, I., & Mihăilescu, P. (1988) · PubMed · Cited by 196
Immunity to Systemic Salmonella Infections
Mastroeni, P. (2002) · Current Molecular Medicine · doi:10.2174/1566524023362492 · Cited by 168 · cited 1×
“In particular, the control of Salmonella proliferation in systemic infections relies on NADPH oxidase-dependent antimicrobial functions of resident phagocytes in the reticuloendothelial system.(12) Patient 14 died of a fulminant sepsis caused by Chromobacterium violaceum, which is a soil and water saprophyte mostly co…”
BackgroundMacher, A. M., Casale, T. B., & Fauci, A. S. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-97-1-51 · Cited by 121 · cited 1×
“violaceum was first reported to occur at unusually high frequency among patients with CGD from southern United States (eg, Florida and Louisiana).(13) A recent literature review by Sirinavin et al(14) found that among 25 pediatric cases of invasive C.”
BackgroundMycobacterial diseases in primary immunodeficiencies
Reichenbach, J., Rosenzweig, S., Döffinger, R., Dupuis, S., Holland, S. M., & Casanova, J.-L. (2001) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/00130832-200112000-00003 · Cited by 112
Gonzalez, B., Moreno, S., BURDACH, R., Valenzuela, M. T., Henriquez, A., Ramos, M. I., & Sorensen, R. U. (1989) · PubMed · Cited by 104
Invasive Chromobacterium violaceum Infection in Children: Case Report and Review
Sirinavin, S., Techasaensiri, C., Benjaponpitak, S., Pornkul, R., & Vorachit, M. (2005) · Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000164761.81491.3f · Cited by 91
The Role of Phagocytic Respiratory Burst in Host Defense Against Mycobacterium tuberculosis
Lau, Y., Chan, G., Ha, S., Hui, Y. F., & Yuen, K. (1998) · Clinical Infectious Diseases · doi:10.1086/517036 · Cited by 72 · cited 7×
“Majority had complicated clinical course, including extrapulmonary involvement, recurrence, and multidrug resistance, but none had miliary TB. Patients 13 and 14 were brothers and had most likely contracted TB from their father.”
ResultInfluentialSelf-citationA novel X-linked recessive form of Mendelian susceptibility to mycobaterial disease
Bustamante, J. C., Pïcard, C., Fieschi, C., Filipe‐Santos, O., Feinberg, J. M., Perronne, C., Chapgier, A. L. A., de Beaucoudrey, L., Vogt, G., Sanlaville, D., et al. (2007) · Journal of Medical Genetics · doi:10.1136/jmg.2006.043406 · Cited by 62 · cited 2×
“Recently, a novel X-linked recessive form of Mendelian susceptibility to mycobacterial diseases was reported, and 2 candidate regions were identified on the X-chromosome.(41) It is expected that there will be identification of more disease-causing genes underlying susceptibility to mycobacterial disease, providing new…”
BackgroundIshibashi, F., Nunoi, H., Endo, F., Matsuda, I., & Kanegasaki, S. (2000) · Human Genetics · doi:10.1007/s004390000288 · Cited by 61 · cited 1×
“In Asia, X-linked CGD is most comprehensively reported in Japan, where more than 200 patients were reported and the estimated incidence rate was 1 in 220,000 births.(3) Information on genetics and clinical characteristics in the Chinese population is scarce.”
BackgroundResponses to reactive oxygen intermediates and virulence of Salmonella typhimurium
Janssen, R., van der Straaten, T., van Diepen, A., & van Dissel, J. T. (2003) · Microbes and Infection · doi:10.1016/s1286-4579(03)00069-8 · Cited by 59 · cited 2×
“Salmonella is a facultative intracellular pathogen, and murine models of CGD have confirmed the importance of reactive oxygen intermediates in killing of Salmonella.11 In particular, the control of Salmonella proliferation in systemic infections relies on NADPH oxidase-dependent antimicrobial functions of resident pha…”
BackgroundÅhlin, A., Lärfars, G., Elinder, G., Palmblad, J., & Gyllenhammar, H. (1999) · Clinical Diagnostic Laboratory Immunology · doi:10.1128/cdli.6.3.420-424.1999 · Cited by 48 · cited 1×
“Recent experiments showed that IFN- could induce production of nitric oxide and related reactive nitrogen species via the action of inducible-nitric oxide synthase; when cocultured with IFN- primed lymphocytes, IFN- stimulated human macrophages exhibit heightened expression of inducible-nitric oxide synthase and mycob…”
BackgroundClinical and laboratory aspects of chronic granulomatous disease in description of eighteen patients
Carnide, E. G., Jacob, C. A., Castro, A. M., & Pastorino, A. C. (2005) · Pediatric Allergy and Immunology · doi:10.1111/j.1399-3038.2005.00225.x · Cited by 47
IFN- γ Is Effective in Reducing Infections in the Mouse Model of Chronic Granulomatous Disease (CGD)
Jackson, S. H., Miller, G. F., Segal, B. H., Mardiney, M., Domachowske, J. B., Gallin, J. I., & Holland, S. M. (2001) · Journal of Interferon & Cytokine Research · doi:10.1089/10799900152547821 · Cited by 40 · cited 1×
“The exact mechanism by which IFN- reduces the infection rate is uncertain, and it was shown that NADPH oxidase activity was not restored in IFN- treatment.(23,24) In the past decade, the role of IFN- in mycobacterial immunity has been increasingly recognized.”
BackgroundDisseminated Mycobacterium flavescens in a probable case of chronic granulomatous disease
Allen, D. M., & Chng, H. H. (1993) · Journal of Infection · doi:10.1016/0163-4453(93)97000-n · Cited by 40
Tuberculosis in New Zealand, 1992-2001: a resurgence
Howie, S., Voss, L., Baker, M., Calder, L., Grimwood, K., & Byrnes, C. (2005) · Archives of Disease in Childhood · doi:10.1136/adc.2004.066415 · Cited by 40 · cited 1×
“2/ 100,000 in those younger than 5 years old).(18) The high incidence of TB observed in our cohort (10.”
BackgroundStasia, M. J., Bordigoni, P., Floret, D., Brion, J., Bost-Bru, C., Michel, G., Gatel, P., Durant-Vital, D., Voelckel, M. A., Li, X. J., et al. (2004) · Human Genetics · doi:10.1007/s00439-004-1208-5 · Cited by 39 · cited 2×
“Most X-linked CGD mutations are found in the coding region, and lead to a lack of gp91 expression because of instability of the mRNA or truncated protein.(9) Many of the mutations identified in the CYBBbase are unique to the respective families, but some mutation “hotspots” are observed.”
BackgroundSegal, B. H., Ding, L., & Holland, S. M. (2003) · Infection and Immunity · doi:10.1128/iai.71.1.205-210.2003 · Cited by 35 · cited 10×
“violaceum infection in murine model, and this might explain the susceptibility to this bacteria in patients with CGD.(15) Drugs that are effective for C.”
BackgroundInfluentialX-Linked Chronic Granulomatous Disease: First Report of Mutations in Patients of Argentina
Barese, C. N., Copelli, S., Zandomeni, R. O., Oleastro, M., Zelazko, M., & Rivas, E. M. (2004) · Journal of Pediatric Hematology/Oncology · doi:10.1097/01.mph.0000139455.29962.be · Cited by 32
Presumed BCG Infection in a Boy with Chronic Granulomatous Disease
Kobayashi, Y., Komazawa, Y., Kobayashi, M., Matsumoto, T., Sakura, N., Ishikawa, K., & Usui, T. (1984) · Clinical Pediatrics · doi:10.1177/000992288402301011 · Cited by 32
von Goessel, H., Hossle, J. P., Seger, R. A., & Güngör, T. (2006) · Experimental Hematology · doi:10.1016/j.exphem.2006.01.005 · Cited by 26
Identification of mutations in seven Chinese patients with X-linked chronic granulomatous disease
Hui, Y., Chan, S. Y., & Lau, Y. (1996) · Blood · doi:10.1182/blood.v88.10.4021.bloodjournal88104021 · Cited by 23 · cited 1×
“We previously reported 6 CYBB gene mutations in 7 Chinese male children.(4) We also observed a high incidence of tuberculosis (TB) in our cohort, suggesting a possible role for phagocytic oxidative bursts in immune response against TB.”
BackgroundSelf-citationLymphadenopathy After BCG Vaccination in a Child with Chronic Granulomatous Disease
Vieira, A. P., Vasconcelos, J. H. L., Fernandes, J. C., Antunes, H., Basto, A. S., Macedo, C., Zaman, A., Santos, E., Melo, J. C. E., & Roos, D. (2004) · Pediatric Dermatology · doi:10.1111/j.0736-8046.2004.21606.x · Cited by 20
Lamhamedi‐Cherradi, S., de Chastellier, C., & Casanova, J. (1999) · Journal of Immunological Methods · doi:10.1016/s0022-1759(99)00030-7 · Cited by 19 · cited 1×
“It was shown that phagocytes from patients with CGD failed to destroy intracellular BCG in vitro compared with phagocytes from healthy individuals, suggesting a role of oxidative bursts in limiting BCG replication.(37) Apart from CGD, disseminated BCG infection has also been reported in other primary immunodeficiency…”
ResultDisseminated BCG infection in a child with chronic granulomatous disease. A case report.
Smith, P. A., & Wittenberg, D. F. (1984) · PubMed · Cited by 17
Movahedi, M., Aghamohammadi, A., Farhoudi, A., Moin, M., Pourpak, Z., Gharagozlou, M., Mansouri, D., Jandaghi, A. B., Shahnavaz, N., Rezaei, N., et al. (2003) · PubMed · Cited by 8
Chronic granulomatous disease: A different pattern in Hong Kong?
Lau, Y., Wong, S. N., Lawton, J. W. M., & Chow, C. (1991) · Journal of Paediatrics and Child Health · doi:10.1111/j.1440-1754.1991.tb00399.x · Cited by 8
Self-citationX-linked chronic granulomatous disease: report of one case.
Weng, J., & Shyur, S. (2004) · PubMed · Cited by 4
Chronic granulomatous disease in two Chinese families.
Yz, L., & Kh, H. (1988) · PubMed · Cited by 2
Cited by
Bustamante, J., Boisson-Dupuis, S., Abel, L., & Casanova, J.-L. (2014) · Seminars in Immunology · doi:10.1016/j.smim.2014.09.008 · Cited by 684
Chronic Granulomatous Disease: The European Experience
van den Berg, J. M., van Koppen, E., Åhlin, A., Belohradsky, B. H., Bernatowska, E., Corbeel, L., Español, T., Fischer, A., Kurenko-Deptuch, M., Mouy, R., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005234 · Cited by 687
“Our data also confirm an increased susceptibility to BCG-itis in CGD patients, as has been recently described [24,25].”
ResultAre Reactive Oxygen Species Always Detrimental to Pathogens?
Paiva, C. N., & Bozza, M. T. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5447 · Cited by 564
“CGD patients have increased susceptibility to M. tuberculosis and also to environmental mycobacteria (32, 158, 165).”
Holland, S. M. (2013) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2012.11.002 · Cited by 348
Current diagnosis and management of peripheral tuberculous lymphadenitis.
Fontanilla, J.-M., Barnes, A., & von Reyn, C. F. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir454 · Cited by 299
“Extrapulmonary tuberculosis, including lymphatic tuberculosis, is more common among immunocompromised patients, including those with HIV infection [20, 21].”
Background
Metadata
- Authors
- Lee, P. P. W., Chan, K.-W., Jiang, L., Chen, T., Li, C., Lee, T.-L., Mak, P. H. S., Fok, S. F. S., Yang, X., & Lau, Y.-L.
- Affiliations
- University of Hong Kong (HK)
- Chongqing Medical University (CN)
- Corresponding author
- Lee, Pamela P. W.
- Chan, Koon-Wing
- Lee, Tsz-Leung
- Mak, Priscilla H. S.
- Fok, Susanna F. S.
- Venue
- Pediatric Infectious Disease Journal
- Published
- 2008-03
- Volume
- 27
- Issue
- 3
- Pages
- 224-230
- ISSN
- 0891-3668 (ISSN-L)
- OpenAlex
- W2053677439
- Cited by
- 158
- References
- 44
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 3 · 2023: 10 · 2022: 11 · 2021: 10 · 2020: 11 · 2019: 7 · 2018: 12 · 2017: 8 · 2016: 8 · 2015: 6 · 2014: 16 · 2013: 10 · 2012: 14
- FWCI
- 3.32
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Pediatric Infectious Disease Journal (publishedVersion)
- PubMed (publishedVersion)
- The HKU Scholars Hub (University of Hong Kong) (submittedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immunodeficiency and Autoimmune Disorders
- Life Sciences › Immunology and Microbiology › Immunology › Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Keywords
- chronic granulomatous disease, X-linked CGD, Mycobacterium tuberculosis infection, BCG infection, respiratory burst, pulmonary aspergillosis, recurrent pneumonia, interferon-gamma, hematopoietic stem cell transplantation, children
- MeSH terms
- Abscess, Adolescent, Animals, Child, Child, Preschool, China, Disease Susceptibility, Granulomatous Disease, Chronic, Humans, Infant, Lymphadenitis, Male, Mutation, Mycobacterium bovis, Mycobacterium tuberculosis, Pneumonia, Tuberculosis, Endemic Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.